Secondary analysis of APPLE study suggests atorvastatin may reduce atherosclerosis progression in pubertal lupus patients with higher C reactive protein.
about
Vitamin D status is a determinant of atorvastatin effect on carotid intima medial thickening progression rate in children with lupus: an Atherosclerosis Prevention in Pediatric Lupus Erythematosus (APPLE) substudyEndothelial progenitor cell phenotype and function are impaired in childhood-onset systemic lupus erythematosus.Prediction and management of cardiovascular outcomes in systemic lupus erythematosus.Why are kids with lupus at an increased risk of cardiovascular disease?Management considerations for childhood-onset systemic lupus erythematosus patients and implications on therapy.Unmet Needs in the Pathogenesis and Treatment of Cardiovascular Comorbidities in Chronic Inflammatory Diseases.Coronary microvascular dysfunction in chronic inflammatory rheumatoid diseases.Update on cardiovascular disease in lupus.Rosuvastatin slows progression of subclinical atherosclerosis in patients with treated HIV infection.The vascular phenotype of children with systemic lupus erythematosus.Subclinical left ventricular dysfunction in childhood-onset systemic lupus erythematosus: a two-dimensional speckle-tracking echocardiographic study.Lipid Testing and Statin Prescription among Medicaid Recipients with Systemic Lupus Erythematosus, Diabetes Mellitus and the General Medicaid Population.Analysis of relationships between 25-hydroxyvitamin D, parathyroid hormone and cathelicidin with inflammation and cardiovascular risk in subjects with paediatric systemic lupus erythematosus: an Atherosclerosis Prevention in Paediatric Lupus Erythem
P2860
Q34478814-5C5E54B1-C615-4C2B-A71B-4AB1AD5559DEQ35901110-143A8981-245C-4A0D-ABAD-DEAD439873DDQ38291820-35874784-2009-4927-8B08-0018E5FB045FQ38591752-FC6A2BF5-010F-46C6-9811-C709A401F11DQ38640910-F9E102A0-814B-46F2-982D-D9F176B99396Q38663003-C93C0B43-D86A-4AB2-BE5B-4A3C41390186Q38749160-7AEDD820-62B3-4CC4-9BBD-851AF8407230Q38844782-DF69F977-DAD7-4A19-ACD2-2F2CC7CCFCCCQ38864670-458B8630-C522-4397-8178-72417E50347CQ40910621-EB71943D-E623-4626-B7F6-312570E7FB9BQ41435721-9FBDD852-0790-4C14-B2DC-500FEDD40ADDQ52592135-7E0E46F1-D66A-4E35-8F3B-78CBB7245881Q55384529-96E0CC2C-81CF-4E82-A7C0-D9A4F6486218
P2860
Secondary analysis of APPLE study suggests atorvastatin may reduce atherosclerosis progression in pubertal lupus patients with higher C reactive protein.
description
2013 nî lūn-bûn
@nan
2013 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Secondary analysis of APPLE st ...... ith higher C reactive protein.
@ast
Secondary analysis of APPLE st ...... ith higher C reactive protein.
@en
type
label
Secondary analysis of APPLE st ...... ith higher C reactive protein.
@ast
Secondary analysis of APPLE st ...... ith higher C reactive protein.
@en
prefLabel
Secondary analysis of APPLE st ...... ith higher C reactive protein.
@ast
Secondary analysis of APPLE st ...... ith higher C reactive protein.
@en
P2093
P2860
P1476
Secondary analysis of APPLE st ...... with higher C reactive protein
@en
P2093
APPLE investigators
Ann M Reed
Anne Eberhard
Carol Wallace
Christy I Sandborg
David D Sherry
Deborah K McCurdy
Deborah Levy
Earl Silverman
Emily von Scheven
P2860
P304
P356
10.1136/ANNRHEUMDIS-2012-202315
P407
P577
2013-02-22T00:00:00Z